Treatment satisfaction with siponimod in patients with advancing relapsing multiple sclerosis: Interim results of the EXCHANGE study

被引：0
|
作者：
Cohan, S. L. [1 ,2 ]
Fox, R. J. [3 ]
Mao-Draayer, Y. [4 ]
Bar-Or, A. [5 ,6 ]
Cox, G. Mavrikis [7 ]
Meng, X. [7 ]
Cruz, L-A [7 ]
Weinstock-Guttman, B. [8 ]
机构：
[1] Providence Hlth & Serv, Providence Brain & Spine Inst, Portland, OR USA
[2] Providence Hlth & Serv, Providence Multiple Sclerosis Ctr, Portland, OR USA
[3] Cleveland Clin, Neurol Inst, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA
[4] Univ Michigan, Multiple Sclerosis Ctr, Autoimmun Ctr Excellence, Ann Arbor, MI 48109 USA
[5] Univ Penn, Perelman Sch Med, Ctr Neuroinflammat & Expt Therapeut, Philadelphia, PA 19104 USA
[6] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA
[7] Novartis Pharmaceut, E Hanover, NJ USA
[8] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Buffalo, NY USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2022年 / 28卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP1145
引用
收藏
页码：901 / 902
页数：2
相关论文
共 50 条
  • [1] Safety and Tolerability of Conversion to Siponimod in Patients with Relapsing Multiple Sclerosis: Interim Results of the EXCHANGE Study
    Bar-Or, Amit
    Weinstock-Guttman, Bianca
    Mao-Draayer, Yang
    Cox, Gina
    Cruz, Linda-Ali
    Meng, Xiangyi
    Su, Wendy
    Cohan, Stanley L.
    NEUROLOGY, 2021, 96 (15)
  • [2] Safety and tolerability of conversion to siponimod in patients with relapsing multiple sclerosis: interim results of the exchange study
    Bar-Or, A.
    Weinstock-Guttman, B.
    Mao-Draayer, Y.
    Cox, G.
    Cruz, L. -A.
    Meng, X.
    Su, W.
    Cohan, S.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 232 - 232
  • [3] Disability status and cognitive functioning in patients with advancing multiple sclerosis switching to siponimod: interim results of the exchange study
    Fox, R. J.
    Weinstock-Guttman, B.
    Mao-Draayer, Y.
    Cohan, S. L.
    Cox, G. Mavrikis
    Meng, X.
    Cruz, L-A
    Bar-Or, A.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 902 - 902
  • [4] Safety and tolerability of conversion to siponimod with and without titration in patients with advancing forms of relapsing multiple sclerosis: interim results of the phase 3b EXCHANGE study
    Bar-Or, A.
    Weinstock-Guttman, B.
    Mao-Draayer, Y.
    Cruz, L. -A.
    Meng, X.
    Cox, G. M.
    Cohan, S. L.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 574 - 575
  • [5] Safety and Tolerability of Conversion to Siponimod in Patients with Advancing Relapsing Multiple Sclerosis: A Subgroup Analysis by Race and Ethnicity of EXCHANGE Interim Data
    Bar-Or, A.
    Weinstock-Guttman, B.
    Mao-Draayer, Y.
    Chinea, A.
    Cox, G. Mavrikis
    Cruz, L.
    Meng, X.
    Cohan, S.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 70 - 70
  • [6] Treatment Sequencing and Satisfaction With Alemtuzumab in Relapsing Multiple Sclerosis Patients: Interim Results of the Real-world PRO-ACT Study
    Wray, Sibyl
    Jacques, Francois
    Miller, Tamara A.
    Nicholas, Jacqueline
    Mozzicato, Susan
    Fanelli, Mary-Jean
    Korideck, Houari
    Kappler, Martin
    Daizadeh, Nadia
    Mitchell, Colin
    Hunter, Samuel F.
    NEUROLOGY, 2019, 92 (15)
  • [7] Siponimod in the treatment of multiple sclerosis
    Goodman, Andrew D.
    Anadani, Nidhiben
    Gerwitz, Lee
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (12) : 1051 - 1057
  • [8] First interim results of Swiss post-marketing surveillance monitoring quality of life and treatment satisfaction in patients with relapsing remitting multiple sclerosis (SWISSASCENT)
    Czaplinski, A.
    Jaquiery, E.
    Stellmes, P.
    Berger, C.
    Kurlandchikov, O.
    Lieder, F.
    Gass, S.
    Maier, T.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 285 - 286
  • [9] Exploring the safety and tolerability of conversion to siponimod in patients with relapsing forms of multiple sclerosis: design of the 6-month prospective EXCHANGE study
    Bar-Or, A.
    Buckle, G. J.
    Cohan, S. L.
    Mao-Draayer, Y.
    Fox, R. J.
    Jaitly, N.
    Cruz, L. -A.
    Kolodny, S.
    Meng, X.
    Tomic, D.
    Su, W.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 779 - 779
  • [10] Treatment satisfaction in patients with highly-active relapsing multiple sclerosis treated with cladribine tablets: clarify-ms study interim analysis
    Brochet, B.
    Hupperts, R. H. Raymond
    Langdon, D.
    Solari, A.
    Piehl, F.
    Lechner-Scott, J.
    Montalban, X.
    Selmaj, K.
    Valis, M.
    Rejdak, K.
    Havrdova, E. Kubala
    Patti, F.
    Alexandri, N.
    Nolting, A.
    Keller, B.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 623 - 623
12345